Clinical Value of Patient‐Derived Tumor Organoids in Guiding Precision Chemotherapy for Locally Advanced Thyroid Cancer: A Single‐Center, Single‐Arm, Phase 2 Trial

Documenti analoghi

• Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial
  di: Benedikt Niedermaier, et al.
  Pubblicazione: (2026)
• Structured Exercise During Chemotherapy for Locally Advanced or Metastatic Pancreatic Cancer: A Single‐Arm, Feasibility Trial
  di: Anita Borsati, et al.
  Pubblicazione: (2026)
• Chemotherapy‐Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline‐Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial
  di: Manuel Hörner, et al.
  Pubblicazione: (2026)
• Factors Influencing Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single‐Center Retrospective Study Focusing on ER and HER‐2 Status
  di: Yadong Zhang, et al.
  Pubblicazione: (2026)
• Vacuum‐Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study)
  di: Hawzhin Hashemi, et al.
  Pubblicazione: (2026)